课件:SysemicluuseryhemaosusSLE系统红斑狼疮.pptVIP

  • 7
  • 0
  • 约1.11万字
  • 约 41页
  • 2019-04-27 发布于广东
  • 举报

课件:SysemicluuseryhemaosusSLE系统红斑狼疮.ppt

课件:SysemicluuseryhemaosusSLE系统红斑狼疮.ppt

(1) Rheumatoid arthritis (RA) Biological agents TNF inhibitors [etanercept (依那西普), infliximab (英夫利西单抗), adalimumab (阿达木单抗) ] were the first licensed biological agents, followed by abatacept (阿巴西普, CTLA-Ig), rituximab (利妥昔单抗), and tocilizumab: they are highly effective. Effects of biological agents can be especially striking in the subset of inadequately treated or non-responsive patients selected for trials. (1) Rheumatoid arthritis (RA) THANK YOU SUCCESS * * 可编辑 (1) Rheumatoid arthritis (RA) ACR50 responses in trials of DMARDs and biological agents ACR50=50% improvements in five

文档评论(0)

1亿VIP精品文档

相关文档